PTX 4.17% 4.6¢ prescient therapeutics limited

Live Investor briefing

  1. 263 Posts.
    lightbulb Created with Sketch. 28


    Live Investor briefing

    Live Investor briefing

    Prescient Therapeutics (ASX: PTX)

    Friday, 10th February 12pm (AEDT)

    Please join Prescient CEO and managing director Steven Yatomi-Clarke for an investor briefing. In this session, Steven will discuss

    How PTX is taking the cancer treatment conversation from ‘fight’ to ‘cure’

    How the company can potentially make any CAR-T developer’s therapies more effective, cheaper and safer

    How its modular platform allows PTX to partner with any CAR-T developer giving them a ‘shovels to the gold rush’ position

    It will be a fascinating look into why Prescient’s highly scalable business model gives them multiple shots on goal in oncology.

    This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.

    Can’t make this time, register to receive the replay.

    https://prescienttherapeutics.investorportal.com.au/




 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.002(4.17%)
Mkt cap ! $37.04M
Open High Low Value Volume
5.0¢ 5.0¢ 4.6¢ $94.55K 2.033M

Buyers (Bids)

No. Vol. Price($)
1 7000 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 550000 2
View Market Depth
Last trade - 15.36pm 03/05/2024 (20 minute delay) ?
Last
4.8¢
  Change
-0.002 ( 2.04 %)
Open High Low Volume
4.7¢ 4.8¢ 4.5¢ 409565
Last updated 15.51pm 03/05/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.